Analysis of drug use of 290 burn patients.
- Author:
Yao-jun WANG
1
;
Ying CEN
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Aged; Anti-Bacterial Agents; economics; therapeutic use; Burns; drug therapy; economics; Child; Child, Preschool; Drug Costs; Drug Utilization; statistics & numerical data; Female; Humans; Infant; Male; Middle Aged; Young Adult
- From: Chinese Journal of Burns 2007;23(5):359-361
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo analyze the drug use in our burn ward, and to investigate the methods in controlling the proportion of drug expenses, as well as the rational use of antibiotics.
METHODSA randomized sample of 290 burn-patients with hospital stay more than 5 days in 2005 were enrolled in the study, and information about their drug use, (especially that of antibiotics), the drug expenses and its proportion in the total medical expenses, the total therapeutic expenses, and the healing rate of the patients were statically analyzed.
RESULTSSulfamido was dominant among the topically applied antibiotics, while cephalosporins was dominant among the systemic applied antibiotics. The drug expenses accounted for (11 +/- 5)% in the therapy expenses, while the antibiotics expenses accounted for (5.8 +/- 1.7)% in the therapy expenses, but it accounted for (51 +/- 17)% in the drug expenses. The average expense of every patient was 22026.09 RMB, and the healing rate of the patients was 96.90%.
CONCLUSIONThe proportion of drug expense (especially that of antibiotics), as well as total medical expenses of burn patients can be lowered through a combined therapy.